Bright Minds Biosciences, Inc. (DRUG.CX)
103.25
+2.17
(+2.15%)
CAD |
CNSX |
Mar 16, 16:00
Bright Minds Biosciences Total Liabilities (Quarterly) : 1.599M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Fennec Pharmaceuticals, Inc. | 74.79M |
| Green Thumb Industries, Inc. | 1.205B |
| Lowell Farms, Inc. | -- |
| Vireo Growth, Inc. | 601.94M |
| Wesana Health Holdings, Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.88M |
| Shareholders Equity (Quarterly) | 89.28M |
| Debt to Equity Ratio | 0.0012 |
| Current Ratio | 57.37 |
| Net Debt Paydown Yield | 0.00% |